Integrative approach to diagnosis of lymphoproliferative disease during long-term Sjogren’s disease. Clinical observation
- Authors: Zeynalova P.A.1,2, Allakhverdieva G.F.1, Ryabukhina Y.E.1, Abbasbeyli F.M.1, Batsev A.F.1, Timofeeva O.L.1, Zhukov A.G.1, Valiev T.T.2
-
Affiliations:
- Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- Issue: Vol 3, No 2 (2023)
- Pages: 41-47
- Section: RARE AND COMPLEX CLINICAL SITUATIONS: DIAGNOSIS AND SELECTION OF TREATMENT TACTICS
- Published: 22.05.2023
- URL: https://mdonco.abvpress.ru/jour/article/view/71
- DOI: https://doi.org/10.17650/2782-3202-2023-3-2-40-46
- ID: 71
Cite item
Full Text
Abstract
During long-term autoimmune processes, most commonly in patients with Sjogren’s disease (SD), lymphoproliferative disorders (LPD) can develop. The risk of mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) with involvement of parotid salivary glands is increased 1,000-fold compared to other immunomorphological variants. Some studies show that the main factors predisposing patients with SD to LPD are long-term enlargement of parotid salivary glands, generalized lymphadenopathy, cryoglobulinemic purpura. Application of an integrative approach to LDP diagnosis in patients with SD, identification of high-risk group for this malignant neoplasm promote its early detection.
A clinical observation of a female patients with long-term SD which was diagnosed along with MALT lymphoma using an integrative approach to diagnosis of both diseases is presented.
About the authors
P. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0003-1564-424X
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Bld. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationG. F. Allakhverdieva
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0001-5910-5892
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationYu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Author for correspondence.
Email: gemonk.yur@mail.ru
ORCID iD: 0000-0001-8443-8816
Yulia Evgenyevna Ryabukhina
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationF. M. Abbasbeyli
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-2359-0547
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationA. F. Batsev
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-1794-7247
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationO. L. Timofeeva
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-6229-7300
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationA. G. Zhukov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0001-5353-8857
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
Russian FederationT. T. Valiev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0002-1469-2365
Bld. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationReferences
- Ramos-Casals M., Tzioufas A.G., Font J. Primary Sjögren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64(1):347–54. doi: 10.1136/ard.2004.025676
- Zhan Q., Zhang J., Lin Y. et al. Pathogenesis and treatment of Sjogren’s syndrome: review and update. Front Immunol 2023;14:1127417. doi: 10.3389/fimmu.2023.1127417
- Vasiljev V.I., Probatova N.A., Tupitsyn N.N. et al. Lymphoproliferative diseases in primary Sjogren’s syndrome. Onkogematologiya = Oncohematology 2007;(3):16–26. (In Russ.). doi: 10.17650/1818-8346-2007-0-3-16-26
- Jonsson R., Brokstad K.A., Jonsson M.V. et al. Current concepts on Sjögren’s syndrome – classification criteria and biomarkers. Eur J Oral Sci 2018;126(Suppl 1):37–48. doi: 10.1111/eos.12536
- Elagib K.E., Børretzen M., Jonsson R. et al. Rheumatoid factors in primary Sjögren’s syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol 1999;117:388–94. doi: 10.1046/j.1365-2249.1999.00963.x
- Salaffi F., Carotti M., Iagnocco A. et al. Ultrasonography of salivary glands in primary Sjögren’s syndrome: a comparison with contrast sialography and scintigraphy. Rheumatology (Oxford) 2008;47(8):1244–9. DOI: 10.1093/ rheumatology/ken222
- Takagi Y., Kimura Y., Nakamura H. et al. Salivary gland ultrasonography: can it be an alternative to sialography as an imaging modality for Sjogren’s syndrome? Ann Rheum Dis 2010;69(7):1321–4. doi: 10.1136/ard.2009.123836
- Torgashina A.V. Ultrasound examination of the salivary glands in Sjogren’s disease. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice 2021;59(4):442–9. (In Russ.). doi: 10.47360/1995-4484-2021-442-449
- Milic V., Petrovic R., Boricic I. et al. Ultrasonography of major salivary glands could be an alternative tool to sialoscintigraphy in the American-European classification criteria for primary Sjogren’s syndrome. Rheumatology (Oxford) 2012;51(6):1081–5. doi: 10.1093/rheumatology/ker431
- Zintzaras E., Voulgarelis M., Moutsopoulos H.M. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005;165(20):2337–44. doi: 10.1001/archinte.165.20.2337
- Ekström Smedby K., Vajdic C.M., Falster M. et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008;111(8):4029–38. doi: 10.1182/blood-2007-10-119974
- Anderson L.A., Gadalla S., Morton L.M. et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. J Int Cancer 2009;125(2):398–405. doi: 10.1002/ijc.24287
- Fragkioudaki S., Mavragani C.P., Moutsopoulos H.M. et al. Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine (Baltimore) 2016;95(25):e3766. doi: 10.1097/MD.0000000000003766
- Ioannidis J.P., Vassiliou V.A., Moutsopoulos H.M. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum 2002;46(3):741–7. doi: 10.1002/art.10221
- Skopouli F.N., Dafni U., Ioannidis J.P., Moutsopoulos H.M. Clinical evolution and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 2000;29(5):296–304. doi: 10.1016/s0049-0172(00)80016-5
- Vasiliev V.I., Logvinenko O.A., Probatova N.A. et al. The role of parotid salivary gland biopsy in the early diagnosis of lymphomas in Sjogren’s disease. Terapevtichesky arhiv = Therapeutic archive 2009;81(6):20–6. (In Russ.).
Supplementary files

